Erratum to “Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA)” (Journal of Diabetes and its Complications (2016) 30(8) (1456–1461) (S1056872716303907) (10.1016/j.jdiacomp.2016.08.009));Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA)

Journal of Diabetes and its Complications

Volumn 30, Issue 8, 2016, Pages 1456-1461

  Martinell, Mats ^a   Dorkhan, Mozhgan ^b   Stålhammar, Jan ^a   Storm, Petter ^b   Groop, Leif ^b   Gustavsson, Carin ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Diabetes; Diabetic macular edema; Diabetic retinopathy; Diabetic retinopathy at diagnosis (DRAD); Latent autoimmune diabetes in the adult (LADA); Type 2 diabetes (T2D)

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C;

ADULT; ADULT DISEASE; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; CARDIOVASCULAR RISK; CELL FUNCTION; DEMOGRAPHY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; EDUCATIONAL STATUS; EYE PHOTOGRAPHY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOLOGIST; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; PANCREAS ISLET BETA CELL; PATHOLOGY; SWEDEN;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; PREVALENCE; RISK FACTORS; SWEDEN;

EID: 84994144983     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2017.02.003     Document Type: Erratum

References (29)

1. ANDIS, All new diabetics in Scania., 2013 Available from http://andis.ludc.med.lu.se.
2. Bennet, L, Johansson, SE, Agardh, CD, Groop, L, Sundquist, J, Rastam, L, et al. High prevalence of type 2 diabetes in Iraqi and Swedish residents in a deprived Swedish neighbourhood—A population based study. BMC Public Health, 11, 2011, 303.
3. Deckers, JG, Schellevis, FG, Fleming, DM, WHO diagnostic criteria as a validation tool for the diagnosis of diabetes mellitus: A study in five European countries. The European Journal of General Practice 12:3 (2006), 108–113.
4. Dunn, OJ, Multiple comparisons among means. Journal of the American Statistical Association 56:293 (1936), 52–64.
5. EQUALIS, Extrernal quality assessment. Available from: http://www.equalis.se/en/start/.
6. Geyer, S, Hemstrom, O, Peter, R, Vagero, D, Education, income, and occupational class cannot be used interchangeably in social epidemiology. Empirical evidence against a common practice. Journal of Epidemiology and Community Health 60:9 (2006), 804–810.
7. Katz, J, Zeger, S, Liang, KY, Appropriate statistical methods to account for similarities in binary outcomes between fellow eyes. Investigative Ophthalmology & Visual Science 35:5 (1994), 2461–2465.
8. Kempen, JH, O'Colmain, BJ, Leske, MC, Haffner, SM, Klein, R, Moss, SE, et al. The prevalence of diabetic retinopathy among adults in the United States. Archives of Ophthalmology 122:4 (2004), 552–563.
9. Klein, R, Davis, MD, Moss, SE, Klein, BE, DeMets, DL, The Wisconsin Epidemiologic Study of Diabetic Retinopathy. A comparison of retinopathy in younger and older onset diabetic persons, Advances in Experimental Medicine and Biology 189 (1985), 321–335.
10. Koo, BK, Kim, SW, Yi, KH, Moon, MK, Low economic status is identified as an emerging risk factor for diabetes mellitus in Korean men aged 30 to 59 years in Korean National Health and Nutrition Examination Survey 2008 to 2010. Diabetes & Metabolism Journal 39:2 (2015), 137–146.
11. Kostev, K, Rathmann, W, Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: A database analysis. Diabetologia 56:1 (2013), 109–111.
12. Looker, HC, Nyangoma, SO, Cromie, D, Olson, JA, Leese, GP, Black, M, et al. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia 55:9 (2012), 2335–2342.
13. Mariotti, SP, Global data on visual impairments 2010. World Health Orgnization. 2012.
14. MONA, Microdata online access 2015. Available from: http://www.scb.se/mona/.
15. Oxford Uo, HOMA calculator 2013. Available from: http://www.dtu.ox.ac.uk/homacalculator/.
16. Raman, R, Gupta, A, Krishna, S, Kulothungan, V, Sharma, T, Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 27). Journal of Diabetes and its Complications 26:2 (2012), 123–128.
17. Rathmann, W, Kostev, K, Lower incidence of recorded cardiovascular outcomes in patients with type 2 diabetes using insulin aspart vs. those on human regular insulin: Observational evidence from general practices. Diabetes, Obesity & Metabolism 15:4 (2013), 358–363.
18. Resnikoff, S, Pascolini, D, Etya'ale, D, Kocur, I, Pararajasegaram, R, Pokharel, GP, et al. Global data on visual impairment in the year 2002. Bulletin World Health Organization 82:11 (2004), 844–851.
19. Ringborg, A, Lindgren, P, Martinell, M, Yin, DD, Schon, S, Stalhammar, J, Prevalence and incidence of type 2 diabetes and its complications 1996–2003—Estimates from a Swedish population-based study. Diabetic Medicine 25:10 (2008), 1178–1186.
20. Robbins, JM, Vaccarino, V, Zhang, H, Kasl, SV, Socioeconomic status and diagnosed diabetes incidence. Diabetes Research and Clinical Practice 68:3 (2005), 230–236.
21. Sacerdote, C, Ricceri, F, Rolandsson, O, Baldi, I, Chirlaque, MD, Feskens, E, et al. Lower educational level is a predictor of incident type 2 diabetes in European countries: The EPIC-InterAct study. International Journal of Epidemiology 41:4 (2012), 1162–1173.
22. Region Skåne, Demography. Available from: http://www.skane.se/sv/Webbplatser/Strukturbild-for-skane/.
23. Statistics Sweden, Available from: http://www.scb.se/sv_/Hitta-statistik/Statistik-efter-amne/Befolkning/.
24. Statistics Sweden PaWD, Sweden, S., (eds.) Longitudinell integrationsdatabas för Sjukförsäkrings- och Arbetsmarknadsstudier (LISA) 1990–2009, 2011.
25. Stratton, IM, Kohner, EM, Aldington, SJ, Turner, RC, Holman, RR, Manley, SE, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44:2 (2001), 156–163.
26. Tapp, RJ, Shaw, JE, Harper, CA, de Courten, MP, Balkau, B, McCarty, DJ, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26:6 (2003), 1731–1737.
27. Tarr, JM, Kaul, K, Chopra, M, Kohner, EM, Chibber, R, Pathophysiology of diabetic retinopathy. ISRN Ophthalmology, 2013, 2013, 343560.
28. The Swedish National Diabetes Register (NDR), Available from: https://www.ndr.nu/-/english.
29. Wilkinson, CP, Ferris, FL III, Klein, RE, Lee, PP, Agardh, CD, Davis, M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:9 (2003), 1677–1682.